June 11, 2021
The defendants in this class action are a number of pharmaceutical companies (such as Teva Pharmaceuticals USA, Inc., Janssen Pharmaceuticals, Inc., and Johnson & Johnson) who have made, promoted or sold a drug called Elmiron. Elmiron is intended to treat interstitial cystitis, which is known as IC or bladder pain syndrome. However, the complaint for this class action claims that it causes damage to the retina, including the macula. It asks for medical monitoring for those who have taken this drug.
Case Event File: Elmiron Patients and Medical Monitoring Massachusetts ComplaintRelated to: Elmiron Patients and Medical Monitoring Massachusetts Class Action
